Cargando…

Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance

Patients with pancreatic-insufficient cystic fibrosis (PI-CF) are at increased risk for developing diabetes. We determined β-cell secretory capacity and insulin secretory rates from glucose-potentiated arginine and mixed-meal tolerance tests (MMTTs), respectively, in pancreatic-sufficient cystic fib...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheikh, Saba, Gudipaty, Lalitha, De Leon, Diva D., Hadjiliadis, Denis, Kubrak, Christina, Rosenfeld, Nora K., Nyirjesy, Sarah C., Peleckis, Amy J., Malik, Saloni, Stefanovski, Darko, Cuchel, Marina, Rubenstein, Ronald C., Kelly, Andrea, Rickels, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204312/
https://www.ncbi.nlm.nih.gov/pubmed/27495225
http://dx.doi.org/10.2337/db16-0394
_version_ 1782489878566535168
author Sheikh, Saba
Gudipaty, Lalitha
De Leon, Diva D.
Hadjiliadis, Denis
Kubrak, Christina
Rosenfeld, Nora K.
Nyirjesy, Sarah C.
Peleckis, Amy J.
Malik, Saloni
Stefanovski, Darko
Cuchel, Marina
Rubenstein, Ronald C.
Kelly, Andrea
Rickels, Michael R.
author_facet Sheikh, Saba
Gudipaty, Lalitha
De Leon, Diva D.
Hadjiliadis, Denis
Kubrak, Christina
Rosenfeld, Nora K.
Nyirjesy, Sarah C.
Peleckis, Amy J.
Malik, Saloni
Stefanovski, Darko
Cuchel, Marina
Rubenstein, Ronald C.
Kelly, Andrea
Rickels, Michael R.
author_sort Sheikh, Saba
collection PubMed
description Patients with pancreatic-insufficient cystic fibrosis (PI-CF) are at increased risk for developing diabetes. We determined β-cell secretory capacity and insulin secretory rates from glucose-potentiated arginine and mixed-meal tolerance tests (MMTTs), respectively, in pancreatic-sufficient cystic fibrosis (PS-CF), PI-CF, and normal control subjects, all with normal glucose tolerance, in order to identify early pathophysiologic defects. Acute islet cell secretory responses were determined under fasting, 230 mg/dL, and 340 mg/dL hyperglycemia clamp conditions. PI-CF subjects had lower acute insulin, C-peptide, and glucagon responses compared with PS-CF and normal control subjects, indicating reduced β-cell secretory capacity and α-cell function. Fasting proinsulin-to-C-peptide and proinsulin secretory ratios during glucose potentiation were higher in PI-CF, suggesting impaired proinsulin processing. In the first 30 min of the MMTT, insulin secretion was lower in PI-CF compared with PS-CF and normal control subjects, and glucagon-like peptide 1 and gastric inhibitory polypeptide were lower compared with PS-CF, and after 180 min, glucose was higher in PI-CF compared with normal control subjects. These findings indicate that despite “normal” glucose tolerance, adolescents and adults with PI-CF have impairments in functional islet mass and associated early-phase insulin secretion, which with decreased incretin responses likely leads to the early development of postprandial hyperglycemia in CF.
format Online
Article
Text
id pubmed-5204312
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-52043122018-01-01 Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance Sheikh, Saba Gudipaty, Lalitha De Leon, Diva D. Hadjiliadis, Denis Kubrak, Christina Rosenfeld, Nora K. Nyirjesy, Sarah C. Peleckis, Amy J. Malik, Saloni Stefanovski, Darko Cuchel, Marina Rubenstein, Ronald C. Kelly, Andrea Rickels, Michael R. Diabetes Pathophysiology Patients with pancreatic-insufficient cystic fibrosis (PI-CF) are at increased risk for developing diabetes. We determined β-cell secretory capacity and insulin secretory rates from glucose-potentiated arginine and mixed-meal tolerance tests (MMTTs), respectively, in pancreatic-sufficient cystic fibrosis (PS-CF), PI-CF, and normal control subjects, all with normal glucose tolerance, in order to identify early pathophysiologic defects. Acute islet cell secretory responses were determined under fasting, 230 mg/dL, and 340 mg/dL hyperglycemia clamp conditions. PI-CF subjects had lower acute insulin, C-peptide, and glucagon responses compared with PS-CF and normal control subjects, indicating reduced β-cell secretory capacity and α-cell function. Fasting proinsulin-to-C-peptide and proinsulin secretory ratios during glucose potentiation were higher in PI-CF, suggesting impaired proinsulin processing. In the first 30 min of the MMTT, insulin secretion was lower in PI-CF compared with PS-CF and normal control subjects, and glucagon-like peptide 1 and gastric inhibitory polypeptide were lower compared with PS-CF, and after 180 min, glucose was higher in PI-CF compared with normal control subjects. These findings indicate that despite “normal” glucose tolerance, adolescents and adults with PI-CF have impairments in functional islet mass and associated early-phase insulin secretion, which with decreased incretin responses likely leads to the early development of postprandial hyperglycemia in CF. American Diabetes Association 2017-01 2016-08-05 /pmc/articles/PMC5204312/ /pubmed/27495225 http://dx.doi.org/10.2337/db16-0394 Text en © 2017 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
spellingShingle Pathophysiology
Sheikh, Saba
Gudipaty, Lalitha
De Leon, Diva D.
Hadjiliadis, Denis
Kubrak, Christina
Rosenfeld, Nora K.
Nyirjesy, Sarah C.
Peleckis, Amy J.
Malik, Saloni
Stefanovski, Darko
Cuchel, Marina
Rubenstein, Ronald C.
Kelly, Andrea
Rickels, Michael R.
Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance
title Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance
title_full Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance
title_fullStr Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance
title_full_unstemmed Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance
title_short Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance
title_sort reduced β-cell secretory capacity in pancreatic-insufficient, but not pancreatic-sufficient, cystic fibrosis despite normal glucose tolerance
topic Pathophysiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204312/
https://www.ncbi.nlm.nih.gov/pubmed/27495225
http://dx.doi.org/10.2337/db16-0394
work_keys_str_mv AT sheikhsaba reducedbcellsecretorycapacityinpancreaticinsufficientbutnotpancreaticsufficientcysticfibrosisdespitenormalglucosetolerance
AT gudipatylalitha reducedbcellsecretorycapacityinpancreaticinsufficientbutnotpancreaticsufficientcysticfibrosisdespitenormalglucosetolerance
AT deleondivad reducedbcellsecretorycapacityinpancreaticinsufficientbutnotpancreaticsufficientcysticfibrosisdespitenormalglucosetolerance
AT hadjiliadisdenis reducedbcellsecretorycapacityinpancreaticinsufficientbutnotpancreaticsufficientcysticfibrosisdespitenormalglucosetolerance
AT kubrakchristina reducedbcellsecretorycapacityinpancreaticinsufficientbutnotpancreaticsufficientcysticfibrosisdespitenormalglucosetolerance
AT rosenfeldnorak reducedbcellsecretorycapacityinpancreaticinsufficientbutnotpancreaticsufficientcysticfibrosisdespitenormalglucosetolerance
AT nyirjesysarahc reducedbcellsecretorycapacityinpancreaticinsufficientbutnotpancreaticsufficientcysticfibrosisdespitenormalglucosetolerance
AT peleckisamyj reducedbcellsecretorycapacityinpancreaticinsufficientbutnotpancreaticsufficientcysticfibrosisdespitenormalglucosetolerance
AT maliksaloni reducedbcellsecretorycapacityinpancreaticinsufficientbutnotpancreaticsufficientcysticfibrosisdespitenormalglucosetolerance
AT stefanovskidarko reducedbcellsecretorycapacityinpancreaticinsufficientbutnotpancreaticsufficientcysticfibrosisdespitenormalglucosetolerance
AT cuchelmarina reducedbcellsecretorycapacityinpancreaticinsufficientbutnotpancreaticsufficientcysticfibrosisdespitenormalglucosetolerance
AT rubensteinronaldc reducedbcellsecretorycapacityinpancreaticinsufficientbutnotpancreaticsufficientcysticfibrosisdespitenormalglucosetolerance
AT kellyandrea reducedbcellsecretorycapacityinpancreaticinsufficientbutnotpancreaticsufficientcysticfibrosisdespitenormalglucosetolerance
AT rickelsmichaelr reducedbcellsecretorycapacityinpancreaticinsufficientbutnotpancreaticsufficientcysticfibrosisdespitenormalglucosetolerance